Global Imaging Diagnostic Catheters Market Overview:
Imaging diagnostic catheters are used to treat patients with cardiovascular diseases. Imaging diagnostic catheters market has high growth prospects owing to increasing patient pool globally. For instance, according to World Health Organization (WHO) 2018 report, cardiovascular diseases accounted for nearly 836,546 deaths in the United States that’s about 1 of every 3 deaths in the United States, and in 2017, cardiovascular diseases (CVDs) caused 3.9 million deaths in Europe. As the numbers of critically ill patients are increasing, demand for cardiac surgery is also on the rise, leading to growing demand of imaging diagnostic catheters.
- Rapid Growth in Geriatric Population
- Growing Prevalence of Cardiovascular Diseases
- Rising Adoption of Minimally Invasive Techniques
- Technological Advancement in the Imaging Diagnostic Catheters
- Lack of Skilled Professionals to Operate Imaging Diagnostic Catheters
- Stringent Government Regulations Regarding Medical Devices
- Increasing Demand of Sterile and Disposable Catheters
- Growing Healthcare Infrastructure in the Developing Countries
- Lack of Advanced Medical Facilities in the Low and Middle Income Group Countries
Some of the key players profiled in the report are Boston Scientific Corporation (United States), St. Jude Medical, Inc. (United States), Medtronic plc. (Ireland), Johnson & Johnson (United States), Koninklijke Philips N.V. (Netherlands), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (United States), C. R. Bard, Inc. (United States) and Edward Lifesciences Corporation (United States). Additionally, following companies can also be profiled that are part of our coverage like St. Jude Medical, Inc. (United States) and Terumo Corporation (Japan). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Imaging Diagnostic Catheters market by 2024. Considering Market by Distribution Channel, the sub-segment i.e. Offline Retail will boost the Imaging Diagnostic Catheters market. Considering Market by End User, the sub-segment i.e. Hospitals will boost the Imaging Diagnostic Catheters market.
21st May 2019 – Medtronic plc launched a telescope guide extension catheter. Which is design to provide additional backup support and access to distal lesions during angioplasty procedures that help to restore blood flow through the coronary and peripheral arteries.
“According to the Food and Drug Administration, to avoid duplicative listings, a cardiovascular device that has two or more types of uses (e.g., used both as a diagnostic device and as a therapeutic device) is listed only in one subpart. Before FDA requires that a device commercially distributed before the enactment date of the amendments, or a device that has been found substantially equivalent to such a device, has approval under section 515 of the act FDA must promulgate a regulation under section 515(b) of the act requiring such approval. Such a regulation under section 515(b) of the act shall not be effective during the grace period ending on the 90th day after its promulgation or on the last day of the 30th full calendar month after the regulation that classifies the device into class III is effective, whichever is later.”
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Imaging Diagnostic Catheters market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Imaging Diagnostic Catheters market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Diagnostic Catheter Manufacturers, Medical Device Manufacturers, Medical Device Distributors, Hospitals, Diagnostic and Imaging Centers, Research Institutes, Government Associations, Research and Consulting Firms, Medical Devices R&D Companies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.